TRANSLAD - Translational medicine in development disorders
  • LabKey Access
  • French
  • English

TRANSLAD - Translational medicine in development disorders

TRANSLAD

A best-practice project focussing specifically on the development of healthcare, research and education in the area of rare developmental disorder diseases.

The principal axes of FHU-TRANSLAD
  • Treat Treat

    A centre for patient evaluation and multidisciplinary care

  • Innovate Innovate

    A diagnostic centre at the cutting edge of molecular genetic technology.

  • Teach and Train Teach and Train

    A training and genomics information referral centre for hereditary diseases

  • Humanise Humanise

    A think-tank on societal and ethical issues

  • Find Find

    A clinical, molecular, neuro-cognitive and pathophysiological research centre

  • Home
  • Introduction
  • Diseases involved
  • Principal Axes
    • Area 1 : Treat
    • Area 2 : Innovate
    • Area 3 : Teach and Train
    • Area 4 : Humanise
    • Area 5 : Find
  • Follow-up
  • Coordination
  • Teams
    • Presentation
    • Diagnostics and healthcare teams included in FHU
    • Research teams included in FHU
    • Teams partnering with FHU-TRANSLAD
  • Support us
  • Home
  • Home
  • Principal Axes
  • Innovate
  • The Dijon Bourgogne University Hospital Functional Unit for innovation in rare disease diagnostics

The Dijon Bourgogne University Hospital Functional Unit for innovation in rare disease diagnostics

Why the need for a dedicated Functional Unit for innovation in rare disease diagnostics ?

FHU TRANSLAD was among the first in France to deploy the high-throughput exome sequencer, initially as a research exercise in identifying new genes responsible for rare diseases, and later more readily used in the diagnosis of rare developmental disorder and intellectual disability diseases. This meant that as early as 2014 the Federation established itself as a point of reference in the introduction of this technology to the area of diagnosis, with the development of efficient bioinformatic pipelines. Its objective is to make genome-wide HTS accessible to all rare disease patients in the Bourgogne region.
This objective, with the full backing of the Dijon Bourgogne University Hospital directorate, led to the creation of a functional unit specifically for innovation in genomic diagnostics for rare disease (UF6254) as part of the biology division, and to the recruitment of Prof. Christophe Philippe, university professor and hospital practitioner of molecular genetics, to head this operation. Co-director Prof. Christel Thauvin shares responsibility for the clinico-biological interface of this operation.
The subsequent introduction in 2015 of the spin-off Orphanomix, in association with SATT-Grand Est, expanded this service across the country to enable patients subject to extended diagnostic delays and awaiting genetic counselling to benefit from this new technology.

The operations of UF6254

Over the years, the team has acquired expertise and experience that have gained national and international recognition, and which are practically applied through a treatment path including ES for patients with rare intellectual disability and/or developmental disorder (ID/DD) diseases, and similarly for certain neurodegenerative diseases. To find out more
HTS is also applied in the molecular diagnosis of somatic mosaic-activating skin disorders within the FIMARAD network. To find out more
The UF6254 operations are staffed by 6 biologists (2 FTE), 5 engineers (2.5 FTE), 3 laboratory technicians (2.5 FTE) and 1 secretary (0.5 FTE).

Area 2 : Innovate

  • Introduction
  • The Dijon Bourgogne University Hospital high-throughput sequencing platform
    • High-throughput sequencing
  • The bioinformatics platform for data analysis
  • The Dijon Bourgogne University Hospital Functional Unit for innovation in rare disease diagnostics
    • Intellectual Disability and Developmental Disorders
    • Mosaic-activating developmental disorders with cutaneous expression
  • The Orphanomix Spin-Off

En savoir plus

Responsable scientifique de la plateforme : Pr Christophe Philippe

Adresse Postale
Laboratoire de Génétique Moléculaire
Plateau Technique de Biologie
2 rue Angélique Ducoudray
CHU le Bocage
21070 DIJON

Other axes

  • Area 1 : Treat
  • Area 2 : Innovate
  • Area 3 : Teach and Train
  • Area 4 : Humanise
  • Area 5 : Find

CHU Dijon - 14 rue Paul Gaffarel - BP 77908 - 21079 Dijon - France
Tél. : 03 80 29 53 13 - Fax : 03 80 29 32 66 - E-mail